These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12903080)

  • 1. Chemical synthesis of novel taurine-containing uridine derivatives.
    Wada T; Shimazaki T; Nakagawa S; Otuki T; Kurata S; Suzuki T; Watanabe K; Saigo K
    Nucleic Acids Res Suppl; 2002; (2):11-2. PubMed ID: 12903080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical synthesis and properties of 5-taurinomethyluridine and 5-taurinomethyl-2-thiouridine.
    Ogata T; Shimazaki T; Umemoto T; Kurata S; Ohtsuki T; Suzuki T; Wada T
    J Org Chem; 2009 Mar; 74(6):2585-8. PubMed ID: 19219973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical synthesis of RNA including 5-taurinomethyluridine and 5-taurinomethyl-2-thiouridine.
    Ogata T; Wada T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):323-4. PubMed ID: 18776384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel taurine-containing uridine derivatives and mitochondrial human diseases.
    Suzuki T; Suzuki T; Wada T; Saigo K; Watanabe K
    Nucleic Acids Res Suppl; 2001; (1):257-8. PubMed ID: 12836362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical synthesis of RNA including 5-taurinomethyluridine.
    Ogata T; Wada T
    Nucleic Acids Symp Ser (Oxf); 2006; (50):9-10. PubMed ID: 17150791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases.
    Suzuki T; Suzuki T; Wada T; Saigo K; Watanabe K
    EMBO J; 2002 Dec; 21(23):6581-9. PubMed ID: 12456664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mt-tRNA components: synthesis of (2-thio)uridines modified with blocked glycine/taurine moieties at C-5,1.
    Leszczynska G; Leonczak P; Dziergowska A; Malkiewicz A
    Nucleosides Nucleotides Nucleic Acids; 2013; 32(11):599-616. PubMed ID: 24138499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of carbocyclic 5'-nor uridine and cytidine derivatives.
    Koga M; Kanda M; Yamamuro T; Tamai K; Uchida T; Suzuki T; Saeki T
    Nucleic Acids Res Suppl; 2002; (2):15-6. PubMed ID: 12903082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and separation of diastereomers of uridine 2',3'-cyclic boranophosphate.
    He K; Shaw BR
    Bioorg Med Chem Lett; 2001 Mar; 11(5):615-7. PubMed ID: 11266154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease.
    Asano K; Suzuki T; Saito A; Wei FY; Ikeuchi Y; Numata T; Tanaka R; Yamane Y; Yamamoto T; Goto T; Kishita Y; Murayama K; Ohtake A; Okazaki Y; Tomizawa K; Sakaguchi Y; Suzuki T
    Nucleic Acids Res; 2018 Feb; 46(4):1565-1583. PubMed ID: 29390138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotides containing 2'-O-[2-(2,3-dihydroxypropyl)amino-2-oxoethyl]uridine as suitable precursors of 2'-aldehyde oligonucleotides for chemoselective ligation.
    Zubin EM; Stetsenko DA; Zatsepin TS; Gait MJ; Oretskaya TS
    Bioorg Med Chem; 2005 Aug; 13(16):4912-20. PubMed ID: 15993079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis and characteristics of modified oligodeoxyribonucleotides containing 2'-O-(2,3-dihydroxypropyl)uridine and 2'-O-(2-exoethyl)uridine].
    Zatsepin TS; Kachalova AV; Romanova EA; Stestenko DA; Gait MJ; Oretskaia TS
    Bioorg Khim; 2001; 27(1):45-51. PubMed ID: 11255642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 4'-selenoribonucleosides.
    Inagaki Y; Minakawa N; Matsuda A
    Nucleic Acids Symp Ser (Oxf); 2007; (51):139-40. PubMed ID: 18029625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of 5- and/or 2-modified 2'-O-cyanoethyl uridine residue: 2'-O-cyanoethyl-5-propynyl-2-thiouridine as an efficient duplex stabilizing component.
    Masaki Y; Miyasaka R; Hirai K; Kanamori T; Tsunoda H; Ohkubo A; Seio K; Sekine M
    Org Biomol Chem; 2014 Feb; 12(7):1157-62. PubMed ID: 24407113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and solution conformation studies of 3-substituted uridine and pseudouridine derivatives.
    Chang YC; Herath J; Wang TH; Chow CS
    Bioorg Med Chem; 2008 Mar; 16(5):2676-86. PubMed ID: 18078759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of taurine in the pathologies of MELAS and MERRF.
    Schaffer SW; Jong CJ; Ito T; Azuma J
    Amino Acids; 2014 Jan; 46(1):47-56. PubMed ID: 23179085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of uridine phosphoramidite analogs: reagents for site-specific incorporation of photoreactive sites into RNA sequences.
    Shah K; Wu H; Rana TM
    Bioconjug Chem; 1994; 5(6):508-12. PubMed ID: 7533002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New methods for the synthesis of N-benzoylated uridine and thymidine derivatives; a convenient method for N-debenzoylation.
    Maguire AR; Hladezuk I; Ford A
    Carbohydr Res; 2002 Feb; 337(4):369-72. PubMed ID: 11841817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and properties of 5-pyrrolyl-cytidine and uridine derivatives.
    Miyata K; Mineo R; Tamamushi R; Taguchi H; Seio K; Sekine M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):15-6. PubMed ID: 17150455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 2'-O-[2-(N-methylcarbamoyl)ethyl]ribonucleosides using oxa-Michael reaction and chemical and biological properties of oligonucleotide derivatives incorporating these modified ribonucleosides.
    Yamada T; Okaniwa N; Saneyoshi H; Ohkubo A; Seio K; Nagata T; Aoki Y; Takeda S; Sekine M
    J Org Chem; 2011 May; 76(9):3042-53. PubMed ID: 21425877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.